1. Home
  2. BGC vs TMDX Comparison

BGC vs TMDX Comparison

Compare BGC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • TMDX
  • Stock Information
  • Founded
  • BGC 1945
  • TMDX 1998
  • Country
  • BGC United States
  • TMDX United States
  • Employees
  • BGC N/A
  • TMDX N/A
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BGC Finance
  • TMDX Health Care
  • Exchange
  • BGC Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • BGC 4.3B
  • TMDX 4.8B
  • IPO Year
  • BGC 1999
  • TMDX 2019
  • Fundamental
  • Price
  • BGC $10.41
  • TMDX $117.63
  • Analyst Decision
  • BGC Strong Buy
  • TMDX Buy
  • Analyst Count
  • BGC 2
  • TMDX 10
  • Target Price
  • BGC $14.50
  • TMDX $127.33
  • AVG Volume (30 Days)
  • BGC 3.4M
  • TMDX 908.5K
  • Earning Date
  • BGC 07-31-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • BGC 0.77%
  • TMDX N/A
  • EPS Growth
  • BGC 128.63
  • TMDX N/A
  • EPS
  • BGC 0.27
  • TMDX 1.41
  • Revenue
  • BGC $2,252,851,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • BGC $35.79
  • TMDX $34.07
  • Revenue Next Year
  • BGC $9.83
  • TMDX $20.76
  • P/E Ratio
  • BGC $39.21
  • TMDX $82.94
  • Revenue Growth
  • BGC 13.24
  • TMDX 64.43
  • 52 Week Low
  • BGC $7.24
  • TMDX $55.00
  • 52 Week High
  • BGC $11.79
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • BGC 59.99
  • TMDX 34.85
  • Support Level
  • BGC $10.21
  • TMDX $122.48
  • Resistance Level
  • BGC $10.96
  • TMDX $127.97
  • Average True Range (ATR)
  • BGC 0.28
  • TMDX 5.69
  • MACD
  • BGC -0.00
  • TMDX -2.22
  • Stochastic Oscillator
  • BGC 64.05
  • TMDX 17.42

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: